Innova Captab

Innova Captab EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is -51.23 %. In the previous year, Year-over-Year EBITDA Growth was 118.43 % — a change of -143.26% (lower).

EBITDA Growth YoY

-51.23 %

YoY

-143.26%

Last updated:

Year-over-Year EBITDA Growth of Innova Captab is 2026 -51.23 % . Year-over-Year EBITDA Growth of Innova Captab was 2025 118.43 % . It decreases by -143.26% lower compared to the previous year.

The Innova Captab EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2019
32.74 INR
Jan 1, 2020
25.12 INR
Jan 1, 2021
-20.47 INR
Jan 1, 2022
79.00 INR
Jan 1, 2023
18.92 INR
Jan 1, 2024
35.11 INR
Jan 1, 2025
118.43 INR
Jan 1, 2026
-51.23 INR
The Innova Captab EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-51.23 %-143.26%
118.43 %+237.32%
35.11 %+85.58%
18.92 %-76.05%
79.00 %-485.84%
-20.47 %-181.50%
25.12 %-23.27%
32.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innova Captab stock

Year-over-Year EBITDA Growth of Innova Captab is -51.23 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Innova Captab since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Innova Captab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Innova Captab

All Key Metrics — Innova Captab